Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Summary Striatal dopamine (DA) is critical for action and learning. Recent data show DA release is under tonic inhibition by striatal GABA. Ambient striatal GABA tone on striatal projection neurons can be governed by plasma membrane GABA uptake transporters (GATs) on astrocytes. However, whether striatal GATs and astrocytes determine DA output are unknown. We reveal that DA release in mouse dorsolateral striatum, but not nucleus accumbens core, is governed by GAT-1 and GAT-3. These GATs are partly localized to astrocytes, and are enriched in dorsolateral striatum compared to accumbens core. In a mouse model of early parkinsonism, GATs were downregulated and tonic GABAergic inhibition of DA release augmented, with corresponding attenuation of GABA co-release from dopaminergic axons. These data define previously unappreciated and important roles for GATs and astrocytes in determining DA release in striatum, and reveal a maladaptive plasticity in early parkinsonism that impairs DA output in vulnerable striatal regions. Highlights <jats:list list-type="order"><jats:list-item> GABA transporters set the level of GABA inhibition of DA output in dorsal striatum <jats:list-item> Astrocytes facilitate DA release levels by limiting tonic GABA inhibition <jats:list-item> Tonic inhibition of DA release is augmented in a mouse model of early parkinsonism <jats:list-item> DA and GABA co-release are reduced in a mouse model of early parkinsonism

Original publication

DOI

10.1101/698274

Type

Journal article

Publication Date

10/07/2019